Study of Anlotinib in Advanced Non-squamous NSCLC Patients in the Elderly Without Systemic Chemotherapy (ALTER-L006)
NCT03778853
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
72
Enrollment
OTHER
Sponsor class
Conditions
Advanced Non-squamous NSCLC
Interventions
DRUG:
Anlotinib Hydrochloride
Sponsor
LanZhou University
Collaborators
[object Object]